RNA Methylation and T Cells in Tumor Immunity: Functions, Therapeutic Strategies, and Prospections

Read full text Summarise with VIRAT
Authors: Shuang Shang, Lifang Ma
Cited by: 0
References: 59

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

RNA methylation is an important post-transcriptional regulatory mechanism that influences gene expression in cancer and immune cells. Dysregulation of RNA methylation has been linked to tumor progression, immune evasion, and therapeutic resistance. In tumor immunity, immune cells function under conditions of persistent antigen stimulation and immunosuppressive signaling, requiring dynamic regulation of RNA metabolism. This chapter summarizes major RNA methylation mechanisms and outlines their regulatory enzymes and immune-related functions. Particular emphasis is placed on the roles of RNA methylation in T cells across different functional stages, including development, activation, expansion, and exhaustion, and how these processes affect antitumor immune responses. These findings highlight RNA methylation as a regulatory layer influencing immunotherapy response and suggest that targeting RNA methylation may provide new strategies to overcome immunotherapy resistance.

Fields of Study & Subjects

RNA modifications and cancer Cancer Immunotherapy and Biomarkers RNA regulation and disease

Publication details

Journal / source
IntechOpen eBooks
Publication date
13 March 2026
Language
EN
Document type
Book chapter